Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • ChIP DNA Quantitation with Low-Range PicoGreen Standard Curve

    Hello everyone,

    We’ve been having problems using the PicoGreen assay to determine our final ChIP DNA samples prior to sample prep for use with the ILMN system. While the high-range standard curve is reasonably linear, the lower portion of the high-range standard curve is clearly not linear, and our samples, we suspect, are in the below 10 ng/ul point on the curve, the lowest point in the high-range standard curve. So we moved to the low-range curve, as described by Invitrogen, which, in every case failed to yield a good standard curve. We don’t know if it is the assay or perhaps the instrument itself. The low-range standard curve is comprised of the following points for reference [0, 25, and 250 PG/ML, and 2.5 and 25 NG/ML]. We are using a Molecular Dynamics SpectraMax M2 instrument.

    So my question is has anyone had success with assaying their ChIP DNA, pre-sample prep., using the PicoGreen assay’s low-range standard curve, particularly with a SpectraMax instrument?

    Lastly, has anyone has success performing ChiP-Seq with starting samples in the 4-6 NG range? In our specific experimentation acquiring the 10+ NG of total sample recommended by ILMN has proven difficult.

    Any insights would be very much appreciated.

    All the best,

    Chandi

Latest Articles

Collapse

  • seqadmin
    Understanding Genetic Influence on Infectious Disease
    by seqadmin




    During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

    Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
    09-09-2024, 10:59 AM
  • seqadmin
    Addressing Off-Target Effects in CRISPR Technologies
    by seqadmin






    The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
    08-27-2024, 04:44 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, Today, 06:25 AM
0 responses
13 views
0 likes
Last Post seqadmin  
Started by seqadmin, Yesterday, 01:02 PM
0 responses
12 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-18-2024, 06:39 AM
0 responses
14 views
0 likes
Last Post seqadmin  
Started by seqadmin, 09-11-2024, 02:44 PM
0 responses
14 views
0 likes
Last Post seqadmin  
Working...
X